368 related articles for article (PubMed ID: 26696207)
1. [Application value of fine needle aspiration and cell block in preoperative diagnosis of thyroid cancer and discrimination of follicular tumor].
Fang Q; Cai C; Chen H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 50(8):668-72. PubMed ID: 26696207
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound Risk Assessment Combined with Molecular Markers of Galectin-3, c-MET, HBME-1 and CK19 for Diagnosis of Malignant and Benign Thyroid Nodules.
Han RL; Wang J; Zhang FJ; Zhao N; Gao BL
Pathol Oncol Res; 2019 Jul; 25(3):1075-1081. PubMed ID: 30361909
[TBL] [Abstract][Full Text] [Related]
3. Improvement of the cytological diagnostic accuracy of follicular thyroid lesions by the use of the Ki-67 proliferative index in addition to cytokeratin-19 and HBME-1 immunomarkers: a study of 61 cases of liquid-based FNA cytology with histological controls.
Lacoste-Collin L; d'Aure D; Bérard E; Rouquette I; Delisle MB; Courtade-Saïdi M
Cytopathology; 2014 Jun; 25(3):160-9. PubMed ID: 24460983
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
Abd-El Raouf SM; Ibrahim TR
Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
[TBL] [Abstract][Full Text] [Related]
6. The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology.
Bizzarro T; Martini M; Marrocco C; D'Amato D; Traini E; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM; Rossi ED
PLoS One; 2015; 10(7):e0132939. PubMed ID: 26186733
[TBL] [Abstract][Full Text] [Related]
7. [The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].
Miseikyte-Kaubriene E; Ulys A; Trakymas M
Medicina (Kaunas); 2008; 44(3):189-94. PubMed ID: 18413985
[TBL] [Abstract][Full Text] [Related]
8. Proteomic identification of new biomarkers and application in thyroid cytology.
Torres-Cabala C; Bibbo M; Panizo-Santos A; Barazi H; Krutzsch H; Roberts DD; Merino MJ
Acta Cytol; 2006; 50(5):518-28. PubMed ID: 17017437
[TBL] [Abstract][Full Text] [Related]
9. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
Tang QS; Teng XD; Ding W; Zhou J; Yao HT; Ying LX; Xu LM
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control.
Cochand-Priollet B; Dahan H; Laloi-Michelin M; Polivka M; Saada M; Herman P; Guillausseau PJ; Hamzi L; Poté N; Sarfati E; Wassef M; Combe H; Raulic-Raimond D; Chedin P; Medeau V; Casanova D; Kania R
Thyroid; 2011 Oct; 21(10):1067-73. PubMed ID: 21875347
[TBL] [Abstract][Full Text] [Related]
11. A core needle biopsy provides more malignancy-specific results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy.
Hakala T; Kholová I; Sand J; Saaristo R; Kellokumpu-Lehtinen P
J Clin Pathol; 2013 Dec; 66(12):1046-50. PubMed ID: 23863219
[TBL] [Abstract][Full Text] [Related]
12. Differences of HBME-1 Expression in Thyroid Follicular Adenoma and Follicular Thyroid Carcinoma by Ultrasound-Guided Fine-Needle Aspiration Biopsy.
Wang J; Xu L; Xu X; Wang X
J Coll Physicians Surg Pak; 2019 Apr; 29(4):337-340. PubMed ID: 30925956
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of suspicious thyroid nodules using four protein biomarkers.
Cerutti JM; Latini FR; Nakabashi C; Delcelo R; Andrade VP; Amadei MJ; Maciel RM; Hojaij FC; Hollis D; Shoemaker J; Riggins GJ
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3311-8. PubMed ID: 16740752
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
Murtezaoglu AR; Gucer H
Pol J Pathol; 2017; 68(1):1-10. PubMed ID: 28547974
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
Teshima M; Tokita K; Ryo E; Matsumoto F; Kondo M; Ikegami Y; Shinomiya H; Otsuki N; Hiraoka N; Nibu KI; Yoshimoto S; Mori T
BMC Cancer; 2019 Mar; 19(1):245. PubMed ID: 30885146
[TBL] [Abstract][Full Text] [Related]
16. Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature.
Dunđerović D; Lipkovski JM; Boričic I; Soldatović I; Božic V; Cvejić D; Tatić S
Diagn Pathol; 2015 Oct; 10():196. PubMed ID: 26503236
[TBL] [Abstract][Full Text] [Related]
17. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.
Ha EJ; Baek JH; Lee JH; Song DE; Kim JK; Shong YK; Hong SJ
Thyroid; 2013 Jun; 23(6):703-8. PubMed ID: 23544697
[TBL] [Abstract][Full Text] [Related]
18. IS MEASUREMENT OF CIRCULATING TUMOR DNA OF DIAGNOSTIC USE IN PATIENTS WITH THYROID NODULES?
Lupo M; Guttler R; Geck Z; Tonozzi TR; Kammesheidt A; Braunstein GD
Endocr Pract; 2018 May; 24(5):453-459. PubMed ID: 29498908
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes.
Pagan M; Kloos RT; Lin CF; Travers KJ; Matsuzaki H; Tom EY; Kim SY; Wong MG; Stewart AC; Huang J; Walsh PS; Monroe RJ; Kennedy GC
BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):6. PubMed ID: 26818556
[TBL] [Abstract][Full Text] [Related]
20. Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules.
Saleh HA; Jin B; Barnwell J; Alzohaili O
Diagn Pathol; 2010 Jan; 5():9. PubMed ID: 20181018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
